NephroDI Therapeutics: Funding, Investors & Team (Aug 2026)
NephroDI Therapeutics is a biopharmaceutical company in Philadelphia, Pennsylvania that specializes in kidney concentration disorders. It was established in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti.
NephroDI Therapeutics has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Jun 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NephroDI Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2024.
NephroDI Therapeutics Funding Rounds
NephroDI Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
NephroDI Therapeutics Funding Compared to Other Biotechnology Startups
NephroDI Therapeutics' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NephroDI Therapeutics in Biotechnology and Philadelphia
Companies Similar to NephroDI Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
NephroDI Therapeutics Funding FAQs
What does NephroDI Therapeutics do?
NephroDI Therapeutics is a biopharmaceutical company in Philadelphia, Pennsylvania that specializes in kidney concentration disorders. It was established in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti.
How much funding has NephroDI Therapeutics raised?
NephroDI Therapeutics has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Jun 2024.
When did NephroDI Therapeutics last raise funding?
NephroDI Therapeutics' most recent funding round on record is an undisclosed round of $2.0M, announced in Jun 2024.
Who founded NephroDI Therapeutics?
FundedIQ lists Ram Pillarisetti (Founder) at NephroDI Therapeutics.
Where is NephroDI Therapeutics headquartered?
NephroDI Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does NephroDI Therapeutics have?
NephroDI Therapeutics is in the 1-10 employee band.
How does NephroDI Therapeutics' funding compare to other Biotechnology startups?
NephroDI Therapeutics' latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NephroDI Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NephroDI Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.